Text For Citation: 02 Item/Group: 005B Hazard:

29 CFR 1910.1450(g)(1)(i):Employees who had developed signs or symptoms associated with a hazardous chemical to which the employee could have been exposed in the laboratory, were not provided an opportunity to receive an appropriate medical examination: On or about February 28, 2022, and at times thereafter, employees who exhibited symptoms associated with acute exposure to methylene chloride (MC) that included, but were not limited to, dizziness; light-headedness; headaches; and impaired gait, were not provided an opportunity to receive the appropriate medical examination when they were exposed to MC in the laboratory while performing extraction procedures with the solvent. Employees presented with symptoms during the following instances: a) February 23, 2022 - Dizziness and fatigue b) February 28, 2022 - Dizziness, fatigue, and tingling and numbness in their feet. c) February 28, 2022 - Nausea d) March 01, 2022- Impaired gait e) March 03, 2022 - Headaches, drowsiness, tingling and numbness in hands and fingers, fatigue f) March 04, 2022 - dizziness, headaches, nausea and fatigue, and respiratory irritation. g) March 04, 2022 - Impaired gait h) March 08, 2022 - Drowsiness and Fatigue i) March 10, 2022 - Impaired gait j) March 15, 2022 - Impaired gait k) April 06, 2022 - Light-headedness and respiratory distress l) May 06, 2022 - Lightheadedness and headache m) May 06, 2022 - Lightheadedness and dizziness